Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance

被引:30
|
作者
Metcalfe, John Z. [1 ]
Streicher, Elizabeth [2 ,3 ]
Theron, Grant [2 ,3 ]
Colman, Rebecca E. [4 ]
Allender, Christopher [5 ]
Lemmer, Darrin [5 ]
Warren, Rob [2 ,3 ]
Engelthaler, David M. [5 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, 1001 Potrero Ave,Rm 5K1, San Francisco, CA 94110 USA
[2] Stellenbosch Univ, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa
[3] Stellenbosch Univ, Fac Med & Hlth Sci, SAMRC Ctr TB Res, Div Mol Biol & Human Genet, Tygerberg, South Africa
[4] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA
[5] Translat Genom Res Inst, Flagstaff, AZ USA
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
next-generation sequencing; Sanger sequencing; drug-resistant tuberculosis; diagnostics; DRUG-RESISTANCE; FLUOROQUINOLONE RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; HETERO-RESISTANCE; GENOMIC ANALYSIS; SOUTH-AFRICA; HETERORESISTANCE; SUSCEPTIBILITY; MUTATIONS; DIAGNOSIS;
D O I
10.1164/rccm.201703-0556OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associated with phenotypic resistance but are poorly detected by Sanger sequencing or commercial molecular diagnostic assays. Objectives: To determine the role of targeted next-generation sequencing in resolving these minor variant subpopulations. Methods: We used single molecule overlapping reads (SMOR), a targeted next-generation sequencing approach that dramatically reduces sequencing error, to analyze primary cultured isolates phenotypically resistant to rifampin, fluoroquinolones, or aminoglycosides, but for which Sanger sequencing found no resistance-associated variants (RAVs) within respective resistance-determining regions (study group). Isolates also underwent single-colony selection on antibiotic-containing agar, blinded to sequencing results. As a positive control, isolates with multiple colocalizing chromatogram peaks were also analyzed (control group). Measurements and Main Results: Among 61 primary culture isolates (25 study group and 36 control group), SMOR described 66 (49%) and 45 (33%) of 135 total heteroresistant RAVs at frequencies less than 5% and less than 1% of the total mycobacterial population, respectively. In the study group, SMOR detected minor resistant variant subpopulations in 80% (n = 20/25) of isolates with no Sanger-identified RAVs (median subpopulation size, 1.0%; interquartile range, 0.2-3.9%). Single-colony selection on drug-containing media corroborated SMOR results for 90% (n = 18/20) of RAV-containing specimens, and the absence of RAVs in 60% (n = 3/5) of isolates. Overall, Sanger sequencing was concordant with SMOR for 77% (n = 53/69) of macroheteroresistant (5-95% total population), but only 5% of microheteroresistant (< 5%) subpopulations (n = 3/66) across both groups. Conclusions: Cryptic minor variant mycobacterial subpopulations exist below the resolving capability of current drug susceptibility testing methodologies, and may explain an important proportion of false-negative resistance determinations.
引用
收藏
页码:1191 / 1201
页数:11
相关论文
共 50 条
  • [1] Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosis
    Eilertson, Brandon
    Maruri, Fernanda
    Blackman, Amondrea
    Herrera, Miguel
    Sterling, Timothy R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (09) : 1276 - 1277
  • [2] Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis
    Kloprogge, Frank
    Canseco, Julio Ortiz
    Phee, Lynette
    Sadouki, Zahra
    Kipper, Karin
    Witney, Adam A.
    Stoker, Neil
    McHugh, Timothy D.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Genotypic and phenotypic resistance of Mycobacterium tuberculosis to rifamycins and fluoroquinolones
    Yew, WW
    Chan, E
    Chan, CY
    Cheng, AF
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (10) : 936 - 937
  • [4] Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis
    Frank Kloprogge
    Julio Ortiz Canseco
    Lynette Phee
    Zahra Sadouki
    Karin Kipper
    Adam A. Witney
    Neil Stoker
    Timothy D. McHugh
    Scientific Reports, 12
  • [5] Association between genotypic and phenotypic pyrazinamide resistance in Mycobacterium tuberculosis
    Whitfield, M. G.
    Streicher, E. M.
    York, T.
    Mardarowicz, I.
    Scott, L.
    Stevens, W.
    van Helden, P. D.
    Warren, R. M.
    Van Rie, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 96 - 96
  • [6] Cryptic disseminated Mycobacterium tuberculosis infection
    Bajwa, R.
    Simpson, G.
    Brown, J.
    RESPIROLOGY, 2023, 28 : 236 - 236
  • [7] Mutations in dnaA and a cryptic interaction site increase drug resistance in Mycobacterium tuberculosis
    Hicks, Nathan D.
    Giffen, Samantha R.
    Culviner, Peter H.
    Chao, Michael C.
    Dulberger, Charles L.
    Liu, Qingyun
    Stanley, Sydney
    Brown, Jessica
    Sixsmith, Jaimie
    Wolf, Ian D.
    Fortune, Sarah M.
    PLOS PATHOGENS, 2020, 16 (11)
  • [8] Phenotypic Heterogeneity in Mycobacterium tuberculosis
    Dhar, Neeraj
    Mckinney, John
    Manina, Giulia
    MICROBIOLOGY SPECTRUM, 2016, 4 (06):
  • [9] Minority Mycobacterium tuberculosis Genotypic Populations as an Indicator of Subsequent Phenotypic Resistance
    Engelthaler, David M.
    Streicher, Elizabeth M.
    Kelley, Erin J.
    Allender, Christopher J.
    Wiggins, Kristin
    Jimenez, Dulce
    Lemmer, Darrin
    Vittinghoff, Eric
    Theron, Grant
    Sirgel, Frederick A.
    Warren, Robin M.
    Metcalfe, John Z.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2019, 61 (06) : 789 - 791
  • [10] Genetic polymorphism and phenotypic resistance of Mycobacterium tuberculosis to fluoroquinolones of different generations
    Lavrenchuk, Leonid
    Umpeleva, Tatyana
    Eremeeva, Natalya
    Vakhrusheva, Diana
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58